KR880000094B1 - 뉴클레오시드 유도체의 제조방법 - Google Patents

뉴클레오시드 유도체의 제조방법 Download PDF

Info

Publication number
KR880000094B1
KR880000094B1 KR1019840007754A KR840007754A KR880000094B1 KR 880000094 B1 KR880000094 B1 KR 880000094B1 KR 1019840007754 A KR1019840007754 A KR 1019840007754A KR 840007754 A KR840007754 A KR 840007754A KR 880000094 B1 KR880000094 B1 KR 880000094B1
Authority
KR
South Korea
Prior art keywords
nucleoside
new
corticosteroid
formula
adenine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019840007754A
Other languages
English (en)
Korean (ko)
Other versions
KR860004919A (ko
Inventor
홍청일
이기홍
김지한
Original Assignee
보령제약 주식회사
김승호
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 보령제약 주식회사, 김승호 filed Critical 보령제약 주식회사
Priority to KR1019840007754A priority Critical patent/KR880000094B1/ko
Priority to KR1019850006039A priority patent/KR880000093B1/ko
Priority to ES549558A priority patent/ES8701192A1/es
Priority to ES549587A priority patent/ES8706163A1/es
Priority to GB08530115A priority patent/GB2168350B/en
Priority to FR8518129A priority patent/FR2574412B1/fr
Priority to GB08530114A priority patent/GB2168353B/en
Priority to FR8518130A priority patent/FR2574411B1/fr
Priority to DE3543346A priority patent/DE3543346C2/de
Priority to JP60275852A priority patent/JPS61197591A/ja
Priority to DE19853543347 priority patent/DE3543347A1/de
Priority to JP60275853A priority patent/JPS61263996A/ja
Publication of KR860004919A publication Critical patent/KR860004919A/ko
Priority to ES557428A priority patent/ES8802363A1/es
Application granted granted Critical
Publication of KR880000094B1 publication Critical patent/KR880000094B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1019840007754A 1984-12-07 1984-12-07 뉴클레오시드 유도체의 제조방법 Expired KR880000094B1 (ko)

Priority Applications (13)

Application Number Priority Date Filing Date Title
KR1019840007754A KR880000094B1 (ko) 1984-12-07 1984-12-07 뉴클레오시드 유도체의 제조방법
KR1019850006039A KR880000093B1 (ko) 1984-12-07 1985-08-22 뉴클레오시드 유도체의 제조방법
ES549558A ES8701192A1 (es) 1984-12-07 1985-12-04 Procedimiento para la preparacion de nucleosidos
ES549587A ES8706163A1 (es) 1984-12-07 1985-12-05 Procedimiento para la fabricacion de nuevos derivados nu- cleosidos
FR8518129A FR2574412B1 (fr) 1984-12-07 1985-12-06 Procede de fabrication de derives de nucleosides utiles notamment comme agents anticancereux
GB08530114A GB2168353B (en) 1984-12-07 1985-12-06 Process for preparing nucleoside derivatives
GB08530115A GB2168350B (en) 1984-12-07 1985-12-06 Nucleoside derivatives
FR8518130A FR2574411B1 (fr) 1984-12-07 1985-12-06 Nouveaux derives de nucleosides, utiles notamment comme medicaments anticancereux, et leur procede de fabrication
DE3543346A DE3543346C2 (de) 1984-12-07 1985-12-07 Verfahren zur Herstellung von Nucleosidkonjugaten
JP60275852A JPS61197591A (ja) 1984-12-07 1985-12-07 ヌクレオシド誘導体の製造方法
DE19853543347 DE3543347A1 (de) 1984-12-07 1985-12-07 Verfahren zur herstellung von nucleosidderivaten
JP60275853A JPS61263996A (ja) 1984-12-07 1985-12-07 新規ヌクレオシド誘導体およびその製造法
ES557428A ES8802363A1 (es) 1984-12-07 1987-02-27 Procedimiento para la fabricacion de derivados nucleosidos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019840007754A KR880000094B1 (ko) 1984-12-07 1984-12-07 뉴클레오시드 유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR860004919A KR860004919A (ko) 1986-07-16
KR880000094B1 true KR880000094B1 (ko) 1988-02-23

Family

ID=19236525

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840007754A Expired KR880000094B1 (ko) 1984-12-07 1984-12-07 뉴클레오시드 유도체의 제조방법

Country Status (6)

Country Link
JP (2) JPS61197591A (enrdf_load_stackoverflow)
KR (1) KR880000094B1 (enrdf_load_stackoverflow)
DE (1) DE3543347A1 (enrdf_load_stackoverflow)
ES (1) ES8701192A1 (enrdf_load_stackoverflow)
FR (1) FR2574412B1 (enrdf_load_stackoverflow)
GB (1) GB2168353B (enrdf_load_stackoverflow)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CN101099745A (zh) 2000-05-26 2008-01-09 艾登尼科斯（开曼）有限公司 处理黄病毒和瘟病毒的方法和组合物
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
ES2624353T3 (es) 2002-11-15 2017-07-13 Idenix Pharmaceuticals Llc 2'-Metil nucleósidos en combinación con interferón y mutación de Flaviviridae
RU2005121904A (ru) 2002-12-12 2006-01-20 Айденикс (Кайман) Лимитед (Ky) Способ получения 2`-разветвленных нуклеозидов
ITFI20040173A1 (it) 2004-08-03 2004-11-03 Protera S R L Profarmaci attivati da dna polimerasi dipendenti da rna
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
TWI464402B (zh) * 2011-01-12 2014-12-11 Univ Kaohsiung Medical 將核酸接上小分子的方法
EP2712868A1 (en) * 2012-09-28 2014-04-02 B. Braun Melsungen AG 5-Fluoruoracil Derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters

Also Published As

Publication number Publication date
DE3543347A1 (de) 1986-06-12
KR860004919A (ko) 1986-07-16
FR2574412B1 (fr) 1989-06-09
ES8701192A1 (es) 1986-12-01
GB2168353B (en) 1988-06-22
FR2574412A1 (fr) 1986-06-13
ES549558A0 (es) 1986-12-01
DE3543347C2 (enrdf_load_stackoverflow) 1989-11-09
JPS61263996A (ja) 1986-11-21
GB8530114D0 (en) 1986-01-15
JPS61197591A (ja) 1986-09-01
GB2168353A (en) 1986-06-18
JPS6338360B2 (enrdf_load_stackoverflow) 1988-07-29
JPH0129800B2 (enrdf_load_stackoverflow) 1989-06-14

Similar Documents

Publication Publication Date Title
AT390000B (de) Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
US5668113A (en) Method of using 1,5-anhydrohexitol nucleoside analogues to treat viral infections
US4963662A (en) Fluorinated nucleosides and method for treating retrovirus infections therewith
WO1992003462A1 (de) Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
JPH069680A (ja) ２’−フルオロ−２’，３’−ジデオキシピリミジンヌクレオシド
HU203363B (en) Process for producing 2',3'-dideoxy-2',2'-difluoronucleosides and pharmaceutical compositions comprising same as active ingredient
US5047520A (en) 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof
KR880000094B1 (ko) 뉴클레오시드 유도체의 제조방법
KR880000093B1 (ko) 뉴클레오시드 유도체의 제조방법
WO1998038202A1 (en) Antiviral phosphonate prodrugs of nucleosides and nucleoside analogues
JPH0699467B2 (ja) ２▲’▼−デオキシ−２▲’▼（ｓ）−アルキルピリミジンヌクレオシド誘導体
DE68929321T2 (de) Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten
EP0817790A1 (de) Spezifische lipidkonjugate von nucleosid-diphosphaten und deren verwendung als arzneimittel
AU5691094A (en) Dihydropyrimidine nucleosides with antiviral properties
US5153180A (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
EP0566162B1 (en) 2'-Methylidenepyrimidine Nucleoside Compounds, their use and method for production thereof
HU204535B (en) Process for producing fluorophosphate derivatives of nukleozides
US4297347A (en) Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
WO1991006555A1 (en) Nucleoside derivative
US5358937A (en) Glycosyl phospholipid derivatives of nucleosides and their use as medicines
Giziewicz et al. 5'-O-methyl derivatives of 1-. beta.-D-arabinofuranosylcytosine and 1-. beta.-D-arabinofuranosyluracil
EP0657465B1 (en) Liponucleotide compounds
KR0170079B1 (ko) 아시클릭 뉴클레오시드의 인지질 유도체 및 이의 제조방법
JPH0543716B2 (enrdf_load_stackoverflow)
GB1588550A (en) Cytidine derivative

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

FPAY Annual fee payment

Payment date: 20020222

Year of fee payment: 15

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 15

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030224

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030224

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301